278 related articles for article (PubMed ID: 30571543)
1. Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension.
Okamoto LE; Shibao CA; Gamboa A; Diedrich A; Raj SR; Black BK; Robertson D; Biaggioni I
Hypertension; 2019 Jan; 73(1):235-241. PubMed ID: 30571543
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in autonomic failure.
Okamoto LE; Shibao C; Gamboa A; Choi L; Diedrich A; Raj SR; Black BK; Robertson D; Biaggioni I
Hypertension; 2012 Mar; 59(3):650-6. PubMed ID: 22311903
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure.
Shibao C; Okamoto LE; Gamboa A; Yu C; Diedrich A; Raj SR; Robertson D; Biaggioni I
Hypertension; 2010 Nov; 56(5):847-51. PubMed ID: 20837887
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.
Ramirez CE; Okamoto LE; Arnold AC; Gamboa A; Diedrich A; Choi L; Raj SR; Robertson D; Biaggioni I; Shibao CA
Hypertension; 2014 Dec; 64(6):1235-40. PubMed ID: 25185131
[TBL] [Abstract][Full Text] [Related]
5. Pyridostigmine treatment trial in neurogenic orthostatic hypotension.
Singer W; Sandroni P; Opfer-Gehrking TL; Suarez GA; Klein CM; Hines S; O'Brien PC; Slezak J; Low PA
Arch Neurol; 2006 Apr; 63(4):513-8. PubMed ID: 16476804
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase inhibition in patients with orthostatic intolerance.
Singer W; Opfer-Gehrking TL; Nickander KK; Hines SM; Low PA
J Clin Neurophysiol; 2006 Oct; 23(5):476-81. PubMed ID: 17016160
[TBL] [Abstract][Full Text] [Related]
7. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
Schreglmann SR; Büchele F; Sommerauer M; Epprecht L; Kägi G; Hägele-Link S; Götze O; Zimmerli L; Waldvogel D; Baumann CR
Eur J Neurol; 2017 Apr; 24(4):545-551. PubMed ID: 28224720
[TBL] [Abstract][Full Text] [Related]
8. Pyridostigmine in the treatment of orthostatic intolerance.
Gales BJ; Gales MA
Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension.
Byun JI; Moon J; Kim DY; Shin H; Sunwoo JS; Lim JA; Kim TJ; Lee WJ; Lee HS; Jun JS; Park KI; Lee ST; Jung KH; Jung KY; Lee SK; Chu K
Neurology; 2017 Sep; 89(10):1078-1086. PubMed ID: 28794253
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine.
Okamoto LE; Diedrich A; Baudenbacher FJ; Harder R; Whitfield JS; Iqbal F; Gamboa A; Shibao CA; Black BK; Raj SR; Robertson D; Biaggioni I
Hypertension; 2016 Aug; 68(2):418-26. PubMed ID: 27271310
[TBL] [Abstract][Full Text] [Related]
11. Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function.
Shibao C; Raj SR; Gamboa A; Diedrich A; Choi L; Black BK; Robertson D; Biaggioni I
Hypertension; 2007 Jul; 50(1):47-53. PubMed ID: 17515448
[TBL] [Abstract][Full Text] [Related]
12. Atomoxetine for Orthostatic Hypotension in an Elderly Patient Over 10 Weeks: A Case Report.
Hale GM; Brenner M
Pharmacotherapy; 2015 Sep; 35(9):e141-8. PubMed ID: 26406777
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
Kaufmann H; Saadia D; Voustianiouk A; Goldstein DS; Holmes C; Yahr MD; Nardin R; Freeman R
Circulation; 2003 Aug; 108(6):724-8. PubMed ID: 12885750
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension.
Singer W; Opfer-Gehrking TL; McPhee BR; Hilz MJ; Bharucha AE; Low PA
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1294-8. PubMed ID: 12933939
[TBL] [Abstract][Full Text] [Related]
15. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
Mathias CJ; Senard JM; Braune S; Watson L; Aragishi A; Keeling JE; Taylor MD
Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
Kuritzky L; Espay AJ; Gelblum J; Payne R; Dietrich E
Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731
[TBL] [Abstract][Full Text] [Related]
17. Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure.
Shibao C; Gamboa A; Abraham R; Raj SR; Diedrich A; Black B; Robertson D; Biaggioni I
Hypertension; 2006 Mar; 47(3):522-6. PubMed ID: 16391172
[TBL] [Abstract][Full Text] [Related]
18. Norepinephrine Reuptake Inhibition, an Emergent Treatment for Neurogenic Orthostatic Hypotension.
Mwesigwa N; Shibao CA
Hypertension; 2024 Jul; 81(7):1460-1466. PubMed ID: 38766862
[TBL] [Abstract][Full Text] [Related]
19. Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study.
Sandroni P; Opfer-Gehrking TL; Singer W; Low PA
Clin Auton Res; 2005 Feb; 15(1):51-3. PubMed ID: 15768203
[TBL] [Abstract][Full Text] [Related]
20. L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.
Kaufmann H
Clin Auton Res; 2008 Mar; 18 Suppl 1():19-24. PubMed ID: 18368303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
